Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Mass General Brigham Health Plan | Autologous Chondrocyte Implantation in the Knee | New policy |
| Aug 2, 2026 | Mass General Brigham Health Plan | Aucatzyl | New policy |
| Aug 2, 2026 | Mass General Brigham Health Plan | Amtagvi | New policy |
| Aug 2, 2026 | Mass General Brigham Health Plan | Adult and Group Adult Foster Care | New policy |
| Aug 2, 2026 | Mass General Brigham Health Plan | Adult Disabled Dependent | New policy |
| Aug 2, 2026 | Mass General Brigham Health Plan | Adult Day Health | New policy |
| Aug 2, 2026 | Mass General Brigham Health Plan | Adstiladrin | New policy |
| Aug 2, 2026 | Mass General Brigham Health Plan | Administratively Necessary Days | New policy |
| Aug 2, 2026 | Mass General Brigham Health Plan | Acupuncture | New policy |
| Aug 2, 2026 | Mass General Brigham Health Plan | Absorbent Products for Incontinence | New policy |
| Aug 2, 2026 | Mass General Brigham Health Plan | Abecma | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP356 Facial Prosthesis | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP355 Aucatzyl (obecabtagene autoleucel) | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP354 Casgevy (exagamglogene autotemcel) | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP352 Intraoperative Neurophysiological Monitoring Services | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP351 Removal of Benign Skin Lesions | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP350 Zynteglo (betibeglogene autotemcel) | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP349 Lyfgenia (lovotibeglogene autotemcel) | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP347 Breyanzi (lisocabtagene maraleucel) | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP346 Carvykti (ciltacabtagene autoleucel) | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP343 Clinical Trial Coverage of Routine Care | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP342 Outpatient Speech Therapy | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP341 Intradialytic Parental Nutrition | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP340 Unspecified Polymerase Chain Reaction Testing | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP339 Urinary Biomarker | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP337 High Tech Radiology Studies (CT-MRI-PET) | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP335 Tecartus (brexucabtagene autoleucel) | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP334 Abecma (idecabtagene vicleucel) | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP333 Adaptive Behavior Treatment (ABT) | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP332 Cell-Free Fetal DNA Testing | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP325 Outpatient Physical and Occupational Therapy | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP324 HIV Resistance Testing | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP271 Infertility Services | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP256 Helicobacter Pylori Testing (003) ss | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP255 Amylase Testing | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP253 Vitamin D Testing | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP252 Thyroid Testing Policy | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP251 Folic Acid Testing | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP249 Chemical Peels and Dermabrasion | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP246 CardioMEMS | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP245 EM Reimbursement Policy | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP238 Erectile Dysfunction Treatment | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP237 Electromyography and Nerve Conduction Study | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP235 Botulinumtoxin Therapy | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP234 Perinatal Care | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP232 Insulin Pump | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP231 Allergy Testing | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP230 Yescarta (Axicabtagene ciloleucel) | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP229 Pasteurized Human Donor Milk | New policy |
| Aug 2, 2026 | MetroPlusHealth | UM-MP228 MRgFUS | New policy |